Concepedia

Andrew R. Jales

AR

Statistics

Publications

5

Citations

82

H-Index

5

Active since

2000

Affiliations

University of Bristol(Current)

University of Bath

University of Michigan

Andrew R. Jales is an author at University of Bristol specializing in medicine, pharmacology, and medicinal chemistry.

Publications per year

2000–2009

5

Publications

5

Selective δ-opioid receptor ligands: potential PET ligands based on naltrindole

Joanne Clayson, Andrew R. Jales, Robin J. Tyacke et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 19 citations · Full text

, , +14

The Role of the Side Chain in Determining Relative δ- and κ-Affinity in C5‘-Substituted Analogues of Naltrindole

Shannon L. Black, Andrew R. Jales, Wolfgang Brandt et al. · Journal of Medicinal Chemistry · 2002 · 17 citations · Full text

, , +15

Selective κ-opioid antagonists related to naltrindole. effect of side-chain spacer in the 5′-amidinoalkyl series

Andrew R. Jales, Stephen M. Husbands, John W. Lewis · Bioorganic & Medicinal Chemistry Letters · 2000 · 17 citations · Full text

, , +11

14β-<i>O</i>-Cinnamoylnaltrexone and Related Dihydrocodeinones are Mu Opioid Receptor Partial Agonists with Predominant Antagonist Activity

H.A. Moynihan, Andrew R. Jales, Benjamin Greedy et al. · Journal of Medicinal Chemistry · 2009 · 16 citations · Full text

, , +17

14-Amino, 14-Alkylamino, and 14-Acylamino Analogs of Oxymorphindole. Differential Effects on Opioid Receptor Binding and Functional Profiles

Peter Grundt, Andrew R. Jales, John R. Traynor et al. · Journal of Medicinal Chemistry · 2003 · 13 citations · Full text

, , +17

1–5 of 5